NGL Fine-Chem informs about credit rating

13 Mar 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements), Regulations, 2015, NGL Fine-Chem has informed that, Crisil Ratings vide their letter dated March 12, 2026 has revised its outlook on the long-term bank loan facilities of the Company to ‘Stable’ from ‘Negative’ while reaffirming the rating at ‘Crisil BBB+’. The Short term rating has been reaffirmed at 'Crisil A2'.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

2187.20 -15.15 (-0.69%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×